版本:
中国

BRIEF-Alere receives FDA CLIA waiver for Alere i RSV rapid molecular test

March 7 Alere Inc -

* Alere receives FDA CLIA waiver for Alere™ i RSV rapid molecular test

* Alere i RSV test has been granted clinical laboratory improvement amendments waiver by FDA for detection of RSV infection in children & adults Source text for Eikon: Further company coverage:

更多 公司新闻(英文)

热门文章

编辑推荐

文章推荐